Optimizing HIV and HCV Treatment and Prevention Among People Experiencing Homelessness
Clinical Practice Guidelines
American Association for the Study of Liver Diseases/Infectious Diseases Society of America.
Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update.
Centers for Disease Control and Prevention/US Public Health Service.
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA panel.
Saag MS, Gandhi RT, Hoy JF, et al. JAMA. 2020;324(16):1651-1669.
Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV.
US Department of Health and Human Services.
Clinician Resources
Housing first in permanent supportive housing
Department of Housing and Urban Development.
Harm Reduction International.
Trauma-informed approaches toolkit.
National Alliance of State and Territorial AIDS Directors.
National Harm Reduction Coalition.
National Health Care for the Homeless Council.
Words matter—terms to use and avoid when talking about addiction.
National Institute on Drug Abuse.
Professional Quality of Life (ProQOL).
SAMHSA’s concept of trauma and guidance for a trauma-informed approach.
Substance Abuse and Mental Health Services Administration (SAMHSA). HHS Publication No. (SMA) 14-4884. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.
Suggested Readings
Implementing an HIV rapid testing-linkage-to-care project among homeless individuals in Los Angeles county: A collaborative effort between federal, county, and city government
Anaya HD, Butler JN, Knapp H, et al. Am J Public Health. 2015;105(1):85-90.
The revolving door of HIV care: revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals.
Ehrenkranz P, Rosen S, Boulle A, et al. PLoS Med. 2021;18(5):e1003651.
Implementation of HIV preexposure prophylaxis in a homeless primary care setting at the Veterans Affairs.
Gregg E, Linn C, Nace E, et al. J Prim Care Community Health. 2020;11:2150132720908370.
HIV treatment outcomes in POP-UP: drop-in HIV primary care model for people experiencing homelessness.
Hickey MD, Imbert E, Appa A, et al. J Infect Dis. 2022;226(Suppl 3):S353-s362.
The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: an Australian pilot study.
Howell J, Traeger MW, Williams B, et al. J Viral Hepat. 2022;29(5):375-384.
Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.
Imbert E, Hickey MD, Clemenzi-Allen A, et al. AIDS. 2021;35(8):1241-1246.
Designing an individually tailored multilevel intervention to increase engagement in HIV and substance use treatment among people who inject drugs with HIV: HPTN 074.
Lancaster KE, Miller WC, Kiriazova T, et al. AIDS Educ Prev. 2019;31(2):95-110.
Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
Masson CL, Fokuo JK, Anderson A, et al. BMC Infect Dis. 2020;20(1):386.
Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: a mixed-methods systematic review.
Paisi M, Crombag N, Burns L, et al. Health Expect. 2022;25(1):48-60.
A pilot outreach HIV testing project among homeless adults.
Pichon LC, Rossi KR, Chapple-McGruder T, et al. Front Public Health. 2021;9:703659.
The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting.
Pilcher CD, Ospina-Norvell C, Dasgupta A, et al. J Acquir Immune Defic Syndr. 2017;74(1):44-51.
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L, Minozzi S, Reed J, et al. Cochrane Database Syst Rev. 2017;9(9):CD012021.
The influence of housing status on the HIV continuum of care: results from a multisite study of patient navigation models to build a medical home for people living with HIV experiencing homelessness.
Rajabiun S, Tryon J, Feaster M, et al. Am J Public Health. 2018;108(S7):S539-s545.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger AJ, Cambiano V, Bruun T, et al. Lancet. 2019;393(10189):2428-2438.
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
Sordo L, Barrio G, Bravo MJ, et al. BMJ. 2017;357:j1550.
Optimizing HIV and HCV Treatment and Prevention Among People Experiencing Homelessness
An Expert Panel Discussion
Relevant Resources
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Evolving Strategies for Diagnosis and Long-Term Management
Consensus and Controversies for Responsible Opioid Prescribing
Best Practices in Combination Therapy
Evolving Approaches to Insulin Based Therapy
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Evolving Best Practices to Optimize Outcomes
The PCPs Role in Preventing HIV
The PCP’s Role in Timely Recognition and Referral
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
Key Issues Impacting OB/GYN Practice
Hot Topics in HBV, HCV, and NASH
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
Improving Patient Outcomes Through Shared Clinical Decision Making
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
Mechanistic Insights and Evolving Treatment Options
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Clinical Resource Center
Understanding the Growing Syndemic — Opioids, HCV, and HIV
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
A PrEP Primer
A Foundation for Managed Care
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Best Practices for Primary Care
New Paths to Chronic Pain Management
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Unlocking Novel Paths to Patient Care
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
Informing the Future of NASH Diagnosis and Assessment
A PEP/PrEP Training Guide for Pharmacists
The Increasing Role of JAK Inhibitors
Preventing COPD Exacerbations to Improve Outcomes
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
A Whole Patient Case Series
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Getting on the Fast Track to Identify AxSpA
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
Reducing LDL-C and a Lifetime of Cardiovascular Risk
Updates, Clinical Scenarios, and Future Directions
A Multidisciplinary Look at Early Diagnosis and Management
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
Best Practices for Diagnosis and Management
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
Are You Aware of New Blood-Based Multi-Cancer Screening Tools
An Updated Clinician’s Guide to Assessment and Management
What the Pharmacist Needs to Know
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Strengthening Your Knowledge of Blood-Based Screening Tools
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
What You Need to Know About New Blood-Based Screening Tools
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis
Practical Updates on the 2023 GOLD Guidelines
A Phone-a-Friend CME Series – Volume 2
Best Practices for Screening, Diagnosis, and Management
Incorporating New Data and Updated Guidelines Into Daily Practice
Focus on Psoriasis
Capitalizing on BCMA-Directed Therapies
From the Airway Epithelium to Improved Patient Outcomes
Exercising Best Practices for Hospitalized Patients
Accelerating Diagnosis and Treatment
